[Federal Register Volume 85, Number 87 (Tuesday, May 5, 2020)]
[Notices]
[Page 26715]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09556]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-636]
Bulk Manufacturer of Controlled Substances Application: Patheon
API Manufacturing, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before July 6, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on February 21, 2020, Patheon A PI Manufacturing, Inc,
309 Delaware Street, Greenville, South Carolina 29605, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............ 2010 I
Alpha-methyltryptamine............... 7432 I
Thebaine............................. 9333 II
Noroxymorphone....................... 9668 II
------------------------------------------------------------------------
The company plans to bulk manufacture the above-listed controlled
substances as an Active Pharmaceutical Ingredient (API) for
distribution to its customers. No other activities for these drug codes
are authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-09556 Filed 5-4-20; 8:45 am]
BILLING CODE 4410-09-P